Rheum for Action
Rheum for Action
Prescription drug affordability boards: Another quick fix with unintended consequences?
Provisions included in some states’ prescription drug affordability boards may allow them to set upper payment limits for medications, potentially...
Rheum for Action
Insurer’s foray into AI-based ‘shared savings’ program creates ethical problems
Liability and ethical concerns arise from a recently proposed voluntary program from Blue Cross and Blue Shield of North Carolina that would...
Rheum for Action
In-office infusions at risk with new Medicare Part B reimbursement recommendation
New recommendations from MedPAC that would lower reimbursements for some Part B drugs threaten to potentially put some practices with infusion...
Rheum for Action
Getting a white-bagging exemption: A win for the patient, employer, and rheumatologist
Costs for specialty drugs can be much higher for both employers with self-funded insurance plans and their employees when they allow an insurance...
Rheum for Action
A little education goes a long way for advocacy
Fellows who learned about the influence that pharmacy benefit managers have on drug costs and access at the Coalition of State Rheumatology...
Rheum for Action
Unintended consequences of perfectly good programs and policies
Dr. Madelaine Feldman describes the unintended consequences of what were thought to be good ideas at the time: Giving safe harbor from the Anti-...
Rheum for Action
Use 2022’s advocacy successes and frustrations as a catalyst for the new year
Dr. Mattie Feldman looks back on the successes and frustrations with health policy legislation and regulation and insurance companies in 2022,...
Rheum for Action
Employers’ self-funded health plans can leave rheumatology patients vulnerable
The CSRO is developing a employer tool kit that educates employers with self-funded health plans about the pitfalls of some of their drug coverage...
Rheum for Action
Who’s in charge here? Rheumatologists battle local Medicare policies threatening access, practice sustainability
Dr. Mattie Feldman explains the advocacy work that the Coalition of State Rheumatology Organizations and other groups are undertaking to address...
Rheum for Action
Will ‘gold card’ legislation and others rein in prior authorizations?
“Gold card” legislation already passed or in the works in several states has potential to reduce prior authorization burdens on clinicians, but...
Rheum for Action
New law will awaken employers to health care’s ‘transparency gap’
Not only will the Consolidated Appropriation Act of 2020-21 help to eliminate much of the “transparency gap” in the system, but it may encourage...